Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.44 |
| ▸ | ADH1C | P00326 | 2/20 | 0.42 |
| ▸ | ADH1A | P07327 | 2/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.42 |
| ▸ | PHGDH | O43175 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10247857 | 0.98 | TSHR (0.43) | TSHRS1PR3S1PR1ADH1CADH1A | |
| SCHEMBL2278722 | 0.84 | SLC6A2 (0.54) | — | |
| SCHEMBL17281560 | 0.83 | TSHR (0.44) | TSHRS1PR3S1PR1ADH1CADH1A | |
| SCHEMBL27689192 | 0.81 | TSHR (0.42) | TSHRS1PR3S1PR1ADH1CADH1A | |
| SCHEMBL19652194 | 0.81 | TSHR (0.43) | TSHRS1PR3S1PR1GAA | |
| SCHEMBL17774457 | 0.80 | ADH1B (0.41) | TSHRADH1CADH1AADH1BFDPS | |
| SCHEMBL12308324 | 0.80 | ADH1C (0.45) | TSHRADH1CADH1AADH1BPHGDH | |
| SCHEMBL10487914 | 0.79 | PHGDH (0.41) | TSHRS1PR3S1PR1PHGDHGAA | |
| SCHEMBL9432694 | 0.79 | PHGDH (0.41) | TSHRS1PR3S1PR1PHGDHGAA | |
| SCHEMBL10247838 | 0.78 | HPGD (0.38) | TSHRS1PR3S1PR1ADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111989336-B | Metal complexes comprising amidine and indole fused cyclopentadienyl ligands | 阿朗新科荷兰有限公司 | 2023-07-07 | — | — | CN | disclosed |
| US-20210363150-A1 | ARYL TRIAZOLE CAGES | UNITED STATES DEPARTMENT OF ENERGY | 2021-11-25 | — | — | US | disclosed |
| US-8647812-B2 | Pattern forming method, chemical amplification resist composition and resist film | FUJIFILM CORPORATION (JP) | 2014-02-11 | — | — | US | disclosed |
| US-20130011619-A1 | PATTERN FORMING METHOD, CHEMICAL AMPLIFICATION RESIST COMPOSITION AND RESIST FILM | FUJIFILM CORPORATION (JP) | 2013-01-10 | — | — | US | disclosed |
| US-20120076996-A1 | RESIST COMPOSITION, RESIST FILM THEREFROM AND METHOD OF FORMING PATTERN THEREWITH | FUJIFILM CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210363150-A1 | ARYL TRIAZOLE CAGES | CAT, SOD1, SOD3 | TSHR 978/4885S1PR3 4598/4885S1PR1 4837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.